1. 抗体
  2. 一抗
  3. 单克隆抗体 重组抗体 流式抗体
  4. HSF1 抗体 (YA896)

HSF1 Antibody (YA896) 是一个兔来源、无偶联标记、抗 HSF1IgG 单克隆抗体。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 价格 是否有货 数量
10 μL ¥493 In-stock
50 μL ¥1281 In-stock
100 μL ¥2100 In-stock
250 μL   询价  

* Please select Quantity before adding items.

  • WB: 蛋白质免疫印迹;
  • IHC-P: 石蜡切片样本的免疫组织化学;
  • IHC-F: 冰冻切片样本的免疫组织化学;
  • ICC/IF: 细胞免疫荧光;
  • IF-Tissue: 组织免疫荧光;
  • mIHC: 多重荧光免疫组化;
  • IP: 免疫沉淀;
  • ChIP: 染色质免疫沉淀;
  • FC: 流式细胞术;
  • ELISA: 酶联免疫吸附试验
  • 产品详情

  • 验证图片

  • 背景信息

  • 产品资料

描述

HSF1 Antibody (YA896) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to HSF1.

宿主

Rabbit

克隆性

Recombinant,Monoclonal

分子量
Predicted band size: 57 kDa;
Observed band size: 80 kDa
请注意:因蛋白存在修饰或聚体等情况,以实测为准,预测仅为参考。
反应种属
Human
蛋白数据库
基因 ID
免疫原

A synthesized peptide derived from human HSF1 aa485-529.

应用 & 推荐
稀释比例
应用 稀释比
WB
WB: 蛋白质免疫印迹
1:500-1:1000
IHC-P
IHC-P: 石蜡切片样本的免疫组织化学
1:50-1:100
ICC/IF
ICC/IF: 细胞免疫荧光
1:50-1:200
IP
IP: 免疫沉淀
1:50
FC
FC: 流式细胞术
1:50-1:100
敏感性 Endogenous 纯度 Affinity Chromatography
偶联 Non-conjugated 修饰 Unmodified
同型 IgG  
性状

液体

组分

Supplied in 50mM Tris-Glycine(pH 7.4), 0.15M NaCl, 40%Glycerol, 0.01% sodium azide and 0.05% BSA.

保存条件 & 期限

Stored at -20°C for 1 year. Avoid repeated freeze / thaw cycles.

运输条件

Shipping with blue ice.

验证图片
ALL WB IHC mIHC
  • Western blot analysis was performed on extracts from Hela (lane 1, 15 μg), HepG2 (lane 2, 15 μg), A431 (lane 3, 15 μg), 293 (lane 4, 15 μg), Jurkat (lane 5, 15 μg), and MCF-7 (lane 6, 15 μg) using HSF1 Rabbit mAb.Proteins were transferred to a PVDF membrane and blocked with 5% non-fat milk in TBST at 4°C overnight.The primary antibody (1:1000 dilution) and the loading control antibody (beta-Actin, HY-P80438, 1:20000 dilution) were incubated in 5% non-fat milk in TBST for 1 hour at 37°C.Goat Anti-Rabbit IgG-HRP Secondary Antibody (1:20000 dilution) was then applied for 40 minutes at 37°C.

  • Immunohistochemical analysis of paraffin-embedded human Lung Adenocarcinoma tissue using HSF1 antibody was performed. The section was pretreated using high-temperature and high-pressure mediated EDTA antigen retrieval buffer (pH 9.0), for 5 minutes. The tissues were incubated with primary antibody (HY-P81052, 1:100 dilution) at room temperature for 60 minutes. Detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. The tissues were counterstained with hematoxylin and mounted with neutral balsam mounting medium.

  • Immunohistochemical analysis of paraffin-embedded human Ovarian Cancer‌ tissue using HSF1 antibody was performed. The section was pretreated using high-temperature and high-pressure mediated EDTA antigen retrieval buffer (pH 9.0), for 5 minutes. The tissues were incubated with primary antibody (HY-P81052, 1:100 dilution) at room temperature for 60 minutes. Detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. The tissues were counterstained with hematoxylin and mounted with neutral balsam mounting medium.

  • Immunohistochemical analysis of paraffin-embedded human Ovarian Cancer‌ tissue using HSF1 antibody was performed. The section was pretreated using high-temperature and high-pressure mediated EDTA antigen retrieval buffer (pH 9.0), for 5 minutes. The tissues were incubated with primary antibody (HY-P81052, 1:100 dilution) at room temperature for 60 minutes. Detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. The tissues were counterstained with hematoxylin and mounted with neutral balsam mounting medium.

  • Immunohistochemical analysis of paraffin-embedded human Ovarian Cancer‌ tissue using HSF1 antibody was performed. The section was pretreated using high-temperature and high-pressure mediated EDTA antigen retrieval buffer (pH 9.0), for 5 minutes. The tissues were incubated with primary antibody (HY-P81052, 1:100 dilution) at room temperature for 60 minutes. Detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. The tissues were counterstained with hematoxylin and mounted with neutral balsam mounting medium.

  • Immunohistochemical analysis of paraffin-embedded human Colon cancer‌ tissue using HSF1 antibody was performed. The section was pretreated using high-temperature and high-pressure mediated EDTA antigen retrieval buffer (pH 9.0), for 5 minutes. The tissues were incubated with primary antibody (HY-P81052, 1:100 dilution) at room temperature for 60 minutes. Detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. The tissues were counterstained with hematoxylin and mounted with neutral balsam mounting medium.

  • Immunohistochemical analysis of paraffin-embedded human Colon cancer‌ tissue using HSF1 antibody was performed. The section was pretreated using high-temperature and high-pressure mediated EDTA antigen retrieval buffer (pH 9.0), for 5 minutes. The tissues were incubated with primary antibody (HY-P81052, 1:100 dilution) at room temperature for 60 minutes. Detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. The tissues were counterstained with hematoxylin and mounted with neutral balsam mounting medium.

  • Tyramide signaling amplification based immunofluorescence was performed on paraffin-embedded human Colon cancer‌ tissue using HSF1 antibody. Antigen retrieval was performed in EDTA buffer pH 9.0 (95 °C, 20 min) followed by cooling to RT. Then incubated with primary antibody (HY-P81052, 1:300 dilution) at room temperature for 60 minutes and HRP conjugated secondary antibody for 10 minutes. Fluorescence was then developed with Vari Fluor 532 TSA (200×)(HY-D1832). The tissues were counterstained with DAPI and mounted with Anti-fade mounting medium.

  • Tyramide signaling amplification based immunofluorescence was performed on paraffin-embedded human Colon cancer‌ tissue using HSF1 antibody. Antigen retrieval was performed in EDTA buffer pH 9.0 (95 °C, 20 min) followed by cooling to RT. Then incubated with primary antibody (HY-P81052, 1:300 dilution) at room temperature for 60 minutes and HRP conjugated secondary antibody for 10 minutes. Fluorescence was then developed with Vari Fluor 532 TSA (200×)(HY-D1832). The tissues were counterstained with DAPI and mounted with Anti-fade mounting medium.

  • Tyramide signaling amplification based immunofluorescence was performed on paraffin-embedded human Colon cancer‌ tissue using HSF1 antibody. Antigen retrieval was performed in EDTA buffer pH 9.0 (95 °C, 20 min) followed by cooling to RT. Then incubated with primary antibody (HY-P81052, 1:300 dilution) at room temperature for 60 minutes and HRP conjugated secondary antibody for 10 minutes. Fluorescence was then developed with Vari Fluor 532 TSA (200×)(HY-D1832). The tissues were counterstained with DAPI and mounted with Anti-fade mounting medium.

  • Tyramide signaling amplification based immunofluorescence was performed on paraffin-embedded human ovarian carcinoma tissue using HSF1 antibody. Antigen retrieval was performed in EDTA buffer pH 9.0 (95 °C, 20 min) followed by cooling to RT. Then incubated with primary antibody (HY-P81052, 1:300 dilution) at room temperature for 60 minutes and HRP conjugated secondary antibody for 10 minutes. Fluorescence was then developed with Vari Fluor 532 TSA (200×)(HY-D1832). The tissues were counterstained with DAPI and mounted with Anti-fade mounting medium.

  • Tyramide signaling amplification based immunofluorescence was performed on paraffin-embedded human ovarian carcinoma tissue using HSF1 antibody. Antigen retrieval was performed in EDTA buffer pH 9.0 (95 °C, 20 min) followed by cooling to RT. Then incubated with primary antibody (HY-P81052, 1:300 dilution) at room temperature for 60 minutes and HRP conjugated secondary antibody for 10 minutes. Fluorescence was then developed with Vari Fluor 532 TSA (200×)(HY-D1832). The tissues were counterstained with DAPI and mounted with Anti-fade mounting medium.

  • Tyramide signaling amplification based immunofluorescence was performed on paraffin-embedded human ovarian carcinoma tissue using HSF1 antibody. Antigen retrieval was performed in EDTA buffer pH 9.0 (95 °C, 20 min) followed by cooling to RT. Then incubated with primary antibody (HY-P81052, 1:300 dilution) at room temperature for 60 minutes and HRP conjugated secondary antibody for 10 minutes. Fluorescence was then developed with Vari Fluor 532 TSA (200×)(HY-D1832). The tissues were counterstained with DAPI and mounted with Anti-fade mounting medium.

背景
功能:作为一种应激诱导型 DNA 结合转录因子,它在热休克反应 (HSR) 的转录激活中起着核心作用,导致一大类分子伴侣——热休克蛋白 (HSP) 的表达,从而保护细胞免受细胞损伤 (PubMed:11447121, PubMed:12659875, PubMed:12917326, PubMed:15016915, PubMed:18451878, PubMed:1871105, PubMed:1986252, PubMed:25963659, PubMed:26754925, PubMed:7623826, PubMed:7760831, PubMed:8940068, PubMed:8946918)。 PubMed:9121459, PubMed:9341107, PubMed:9499401, PubMed:9535852, PubMed:9727490)。在未受胁迫的细胞中,它存在于含有 HSP90 的多分子伴侣复合物中,该复合物使其保持非 DNA 结合的失活单体形式 (PubMed:11583998, PubMed:16278218, PubMed:9727490)。暴露于热和其他应激刺激时,发生同源三聚化,并通过与 HSP 基因启动子区域中存在的位点特异性热休克元件 (HSE) 结合来激活 HSP 基因转录 (PubMed:10359787, PubMed:11583998, PubMed:12659875, PubMed:16278218, PubMed:1871105, PubMed:1986252, PubMed:25963659, PubMed:26754925, PubMed:7623826, PubMed:7935471, PubMed:8455624, PubMed:8940068, PubMed:9499401, PubMed:9727490)。在热休克应激下,该蛋白与 TTC5/STRAP 和 p300/EP300 形成染色质相关复合物,从而刺激热休克反应 (HSR) 转录,进而提高细胞存活率 (PubMed:18451878)。该蛋白的激活是可逆的,在 HSR 的衰减和恢复期,该蛋白会恢复到未激活状态 (PubMed:11583998, PubMed:16278218)。该蛋白可与反向的 5'-NGAAN-3'五聚体 DNA 序列结合 (PubMed:1986252, PubMed:26727489)。该蛋白还可与热休克基因启动子处的染色质结合 (PubMed:25963659)。激活转录因子 FOXR1 的转录,进而激活热休克分子伴侣 HSPA1A 和 HSPA6 以及抗氧化剂 NADPH 依赖性还原酶 DHRS2 的转录 (PubMed:34723967)。此外,它还具有一些独立于其转录活性的其他功能。参与抑制热应激细胞中 Ras 诱导的 c-fos 基因转录激活 (PubMed:9341107)。以 symplekin (SYMPK) 依赖的方式正向调控热应激细胞中 HSP70 mRNA 前体 3'端加工和多聚腺苷酸化 (PubMed:14707147)。在应激诱导的 HSP70 mRNA 的核输出中发挥作用 (PubMed:17897941)。在有丝分裂进程的调控中发挥作用 (PubMed:18794143)。它还以 DNA 损伤依赖的方式作为非同源末端连接 (NHEJ) 修复活性的负调控因子发挥作用 (PubMed:26359349)。它以 IER5 依赖的方式参与应激诱导的癌细胞增殖 (PubMed:26754925);(微生物感染) 在潜伏性人类免疫缺陷病毒 (HIV-1) 转录激活中发挥作用。它与 HIV-1 长末端重复序列启动子 (LTR) 结合,通过募集细胞转录延伸因子 (如 CDK9、CCNT1 和 EP300) 来激活病毒转录。
亚细胞定位:细胞核;细胞质;细胞核、核质;细胞质、核周区;细胞质、细胞骨架、纺锤体极;细胞质、细胞骨架、微管组织中心、中心体;染色体、着丝粒、动粒
异构体 & 翻译后修饰:Q00613 有两种异构体:Q00613-1:57260 Da (预测值);Q00613-2:52881 Da (预测值)。
磷酸化 (PubMed:10359787, PubMed:11583998, PubMed:26159920, PubMed:9499401)。在未受胁迫的细胞中发生磷酸化;这种磷酸化是组成型的,并与 HSF1 转录活性的抑制有关 (PubMed:16278218, PubMed:8940068, PubMed:8946918, PubMed:9121459)。MAPKAPK2 在 Ser-121 位点磷酸化;这种磷酸化促进 HSF1 与 HSP90 蛋白的相互作用,并抑制 HSF1 的同源三聚化、DNA 结合和转录激活活性 (PubMed:16278218)。GSK3B/GSK3-β对 Ser-303 位点的磷酸化以及 MAPK3 对 Ser-307 位点的磷酸化均参与抑制 HSF1 的转录活性,且该过程依赖于 RAF1 (PubMed:10747973, PubMed:12646186, PubMed:8940068, PubMed:8946918, PubMed:9121459, PubMed:9535852)。Ser-303 和 Ser-307 位点的磷酸化以 YWHAE 和 XPO1/CRM1 依赖的方式增加 HSF1 的核输出 (PubMed:12917326)。 Ser-307 的磷酸化是 Ser-303 磷酸化的先决条件 (PubMed:8940068)。根据 PubMed:9535852,Ser-303 在未受胁迫的细胞中不发生磷酸化。PLK1 可磷酸化 Ser-419;该磷酸化促进热休克后蛋白的核转位 (PubMed:15661742)。在热休克以及热休克反应的衰减和恢复期,该蛋白发生过度磷酸化 (PubMed:11447121, PubMed:12659875, PubMed:24581496)。Thr-142 发生磷酸化;该磷酸化增强热休克后 HSF1 的转录激活活性 (PubMed:12659875)。CAMK2A 可磷酸化 Ser-230;这种磷酸化作用增强了热休克后 HSF1 的转录激活活性 (PubMed:11447121)。MAPK12 对 Ser-326 位点的磷酸化作用增强了热休克后 HSF1 的核转位、同源三聚化和转录激活活性 (PubMed:15760475, PubMed:27354066)。PRKACA/PKA 对 Ser-320 位点的磷酸化作用促进了热休克后 HSF1 的核定位和转录活性 (PubMed:21085490)。MAPK8 对 Ser-363 位点的磷酸化作用发生在热休克时,诱导 HSF1 转位至核应激体并负调控其转录激活活性 (PubMed:10747973)。调控域内的 Ser-230、Ser-292、Ser-303、Ser-307、Ser-314、Ser-319、Ser-320、Thr-323、Ser-326、Ser-338、Ser-344、Ser-363、Thr-367、Ser-368 和 Thr-369 位点的基础磷酸化和应激诱导磷酸化均不参与 HSF1 亚细胞定位或 DNA 结合活性的调控;然而,它负调控 HSF1 的转录激活活性 (PubMed:25963659)。在有丝分裂早期,PLK1 可磷酸化 Ser-216 位点;这种磷酸化调节 HSF1 定位到纺锤体极,募集 SCF (BTRC) 泛素连接酶复合物诱导 HSF1 降解,从而影响有丝分裂进程 (PubMed:18794143)。磷酸酶 PPP2CA 以 IER5 依赖的方式使 HSF1 在 Ser-121、Ser-307、Ser-314、Thr-323 和 Thr-367 位点去磷酸化,导致 HSF1 介导的转录激活活性 (PubMed:26754925);热休克后,HSF1 以 ERK2 依赖的方式被 SUMO1 和 SUMO2 修饰 (PubMed:12646186, PubMed:12665592)。SUMO1 在 Lys-298 位点进行 SUMO 修饰;热休克后发生 SUMO 化修饰,促进其定位至核应激体并增强 DNA 结合活性 (PubMed:11514557)。Ser-303 和 Ser-307 的磷酸化可能是 SUMO 化的先决条件 (PubMed:12646186, PubMed:12665592);Lys-118 乙酰化;该乙酰化作用以 IER5 依赖的方式降低 (PubMed:26754925)。Lys-118、Lys-208 和 Lys-298 乙酰化;这些乙酰化作用以 EP300 依赖的方式发生 (PubMed:24581496, PubMed:27189267)。Lys-80 乙酰化;该乙酰化修饰在热休克时抑制 DNA 结合活性 (PubMed:19229036)。SIRT1 介导 Lys-80 位点的去乙酰化;该去乙酰化修饰增强 DNA 结合活性 (PubMed:19229036);SCF (BTRC) 介导其泛素化,并在有丝分裂过程中,PLK1 介导 Ser-216 位点的刺激依赖性磷酸化后降解 (PubMed:18794143)。多聚泛素化 (PubMed:24581496)。在热休克时以及热休克反应的衰减和恢复期,均发生蛋白酶体降解 (PubMed:24581496)。
亚基:单体;在未受胁迫的细胞中,胞质内潜伏且转录不活跃的单体形式 (PubMed:11583998, PubMed:7623826, PubMed:7935376, PubMed:7935471, PubMed:8455624, PubMed:9222587, PubMed:9727490)。同源三聚体;在热休克等应激反应中,该蛋白发生同源三聚化并转位至细胞核,与热休克蛋白 (HSP) 基因启动子中的热休克元件 (HSE) 序列结合,获得转录活性 (PubMed:11583998, PubMed:26727489, PubMed:26754925, PubMed:7623826, PubMed:7935471, PubMed:8455624, PubMed:9222587, PubMed:9727490)。该蛋白 (以单体形式) 与 FKBP4 相互作用;这种相互作用发生在未受应激的细胞中 (PubMed:11583998)。该蛋白 (以单体形式) 在未受应激的细胞中与 HSP90 蛋白结合,形成多分子伴侣复合物;这种关联通过阻止 HSF1 同源三聚体化,使 HSF1 保持非 DNA 结合和转录失活状态 (PubMed:11583998, PubMed:15661742, PubMed:16278218, PubMed:9727490)。同源三聚体转录激活活性受蛋白质-蛋白质相互作用和翻译后修饰的调控 (PubMed:11583998, PubMed:15016915, PubMed:16554823, PubMed:26754925)。HSF1 与 HSP90AA1 相互作用;这种相互作用以 IER5 依赖的方式减弱,从而促进 HSF1 在细胞核内的积累、同源三聚体化和 DNA 结合活性 (PubMed:26754925)。 HSF1 (通过其同源三聚体形式的调控结构域) 是至少由 FKBP4、FKBP5、HSP90 蛋白、PPID、PPP5C 和 PTGES3 组成的大型热休克诱导的 HSP90 依赖性多分子伴侣复合物的一部分;这种结合维持 HSF1 同源三聚体 DNA 结合形式处于转录非活性状态 (PubMed:11583998, PubMed:16278218, PubMed:9727490)。HSF1 (通过其 BAG 结构域) 与 BAG3 相互作用;这种相互作用发生在正常细胞和热休克细胞中,以 BAG3 依赖的方式促进 HSF1 的核穿梭 (PubMed:26159920)。HSF1 (通过其同源三聚体和高磷酸化形式) 与 FKBP4 相互作用;这种相互作用发生在热休克时,存在于 HSP90 依赖性多分子伴侣复合物中 (PubMed:11583998)。优先以同源三聚体形式与 EEF1A 蛋白相互作用 (PubMed:15016915)。在热休克细胞中,应激变性蛋白与 HSF1 同源三聚体 DNA 结合形式竞争 HSP90 依赖性多分子伴侣复合物的结合位点,从而缓解 HSF1 介导的转录活性抑制 (PubMed:11583998)。优先以同源三聚体形式与 DAXX 相互作用;这种相互作用可解除热休克时 HSP90 依赖性多分子伴侣复合物对同源三聚体 HSF1 转录活性的抑制 (PubMed:15016915)。优先以 D 结构域与 JNK1 相互作用 (优先与高磷酸化形式相互作用);这种相互作用发生在正常生长条件下以及热休克后立即发生 (PubMed:10747973)。优先以 D 结构域与 MAPK3 相互作用 (优先与高磷酸化形式相互作用)。这种相互作用发生在热休克时 (PubMed:10747973)。它与 IER5 (通过中心区域) 相互作用;这种相互作用促进 PPP2CA 诱导的 Ser-121、Ser-307、Ser-314、Thr-323 和 Thr-367 位点的去磷酸化以及 HSF1 的转录激活活性 (PubMed:25816751, PubMed:26496226, PubMed:26754925)。它存在于由 HSF1 同源三聚体、翻译延伸因子 eEF1A 蛋白和非编码 RNA 热休克 RNA-1 (HSR1) 组成的核糖核蛋白复合物中;这种复合物在热休克时形成,并刺激 HSF1 的 DNA 结合活性 (PubMed:16554823)。它 (通过转录激活结构域) 与 HSPA1A/HSP70 和 DNAJB1 相互作用;这些相互作用导致在热休克减弱和恢复期,热休克和 HSF1 诱导的转录活性受到抑制 (PubMed:7935376, PubMed:9222587, PubMed:9499401)。它通过 Ser-303 和 Ser-307 磷酸化形式与 YWHAE 相互作用;这种相互作用以 ERK 依赖的方式促进 HSF1 在细胞质中的隔离 (PubMed:12917326)。它与 IER5 和 PPP2CA 形成复合物 (PubMed:26754925)。它与 TPR 相互作用;这种相互作用在热休克后增强,并刺激 HSP70 mRNA 的输出 (PubMed:17897941)。它通过 N 端与 SYMPK 和 CSTF2 相互作用;这些相互作用发生在热休克期间 (PubMed:14707147)。通过转录激活结构域与 HSPA8 相互作用 (PubMed:9499401)。与 EEF1D 相互作用;这种相互作用发生在热休克启动子元件 (HSE) 序列处 (PubMed:21597468)。与 MAPKAPK2 相互作用 (PubMed:16278218)。与 PRKACA/PKA 相互作用 (PubMed:21085490)。通过转录激活结构域与 GTF2A2 相互作用 (PubMed:11005381)。通过转录激活结构域与 GTF2B 相互作用 (PubMed:11005381)。通过转录激活结构域与 TBP 相互作用 (PubMed:11005381)。与 CDK9、CCNT1 和 EP300 相互作用 (PubMed:27189267)。通过 N 端与 XRCC5 (通过 N 端) 和 XRCC6 (通过 N 端) 相互作用;这些相互作用是直接的,可阻止 XRCC5/XRCC6 异二聚体结合以及电离辐射 (IR) 诱导的非同源末端连接 (NHEJ) 修复活性 (PubMed:26359349)。与 PLK1 相互作用;这种相互作用发生在有丝分裂早期,在热休克后增强,但不调节 HSF1 同源三聚化和 DNA 结合活性 (PubMed:15661742, PubMed:18794143)。通过 Ser-216 磷酸化形式与 CDC20 相互作用;这种相互作用发生在有丝分裂期,且依赖于 MAD2L1,它通过阻断 SCF (BTRC) 泛素连接酶复合物的募集来阻止 PLK1 刺激的 HSF1 降解 (PubMed:18794143)。与 MAD2L1 相互作用;这种相互作用发生在有丝分裂期 (PubMed:18794143)。与 BTRC 相互作用;这种相互作用发生在有丝分裂期,在 Ser-216 位点发生刺激依赖性磷酸化后,诱导 BTRC 的泛素依赖性降解,该过程受 CDC20 抑制 (PubMed:18794143)。与 HSP90AA1 和 HSP90AB1 相互作用 (PubMed:26517842)。与 TTC5/STRAP 和 p300/EP300 形成复合物;这些相互作用增强了染色质结合的 HSF1 和 p300/EP300 组蛋白乙酰转移酶活性 (PubMed:18451878)
RRID
反应种属数据库
研究领域

Tags & Cell Markers

中文名
HSF1 抗体 (YA896)
同用名
HSF1; HSTF1; Heat shock factor protein 1; HSF 1; Heat shock transcription factor 1; HSTF 1
文件资料
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
HSF1 Antibody (YA896)
目录号:
HY-P81052
需求量: